SYDNEY--(BUSINESS WIRE)--Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology ...
16 December 2021 — Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a AU$35m Series B funding round, led by ...
24 August 2021 — Inventia Life Science, together with BioLamina AB, a Swedish biotechnology company leading in matrix biology and cell culture-based research, have entered into a partnership in order ...
SYDNEY, April 16, 2026--(BUSINESS WIRE)--Inventia Life Science today announced the launch of RASTRUM™ Validated Solutions, a new product offering designed to help drug discovery teams generate ...
DUBLIN--(BUSINESS WIRE)--Inventia Life Science, a leading advanced cell model company, launched the Inventia Third Dimension Grant today. This grant will allow researchers studying fundamental biology ...
Invengene and Nutriventia, the injectables and nutraceuticals businesses, respectively, are not part of the transaction and are being retained separately by the Shah family Barclays served as ...
Inventia Healthcare Limited, a global pharmaceutical development and manufacturing company, announced that the US Food and Drug Administration (FDA) has approved Inventia’s Abbreviated New Drug ...
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM(TM) Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results